Item 4. Controls and Procedures.

Controls and Procedures.

We,

under the

supervision and

with the

participation of

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

have

evaluated

the

effectiveness

of

the design

and

operation

of

our

disclosure

controls

and

procedures

(as

defined

in

Rule

13a-15(e)

under

the

Securities

Exchange

Act

of

1934).

Based

on

our

evaluation,

our

Chief

Executive

Officer

and

Chief

Financial

Officer

have

concluded

that,

as

of

November

24,

2024,

our

disclosure

controls

and

procedures

were

effective

to

ensure

that

information required to

be disclosed by us

in reports that we

file or submit under

the Securities Exchange Act

of 1934 is (1)

recorded,

processed, summarized,

and reported

within the

time periods

specified in

Securities and

Exchange Commission

rules and

forms, and

(2)

accumulated

and

communicated

to

our

management,

including

our

Chief

Executive

Officer

and

Chief

Financial

Officer,

in

a

manner that allows timely decisions regarding required disclosure.

There were no changes in our internal

control over financial reporting (as defined

in Rule 13a-15(f) under the Securities Exchange

Act

of

during

the

quarter

ended

November

24,

2024,

that

materially

affected,

or

are

reasonably

likely

to

materially

affect,

our

internal control over financial reporting.

PART

II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

The

following

table

sets forth

information

with

respect

to

shares

of

our

common

stock

that we

purchased

during

the quarter

ended

November 24, 2024:

Period

Total

Number

of Shares

Purchased (a)

Average

Price Paid

Per Share

Total

Number of Shares

Purchased as Part of a Publicly

Announced Program (b)

Maximum Number of Shares

that may yet be Purchased

Under the Program (b)

August 26, 2024 -

September 29, 2024

1,711,787

$

74.19

1,711,787

49,414,101

September 30, 2024 -

October 27, 2024

2,022,335

71.76

2,022,335

47,391,766

October 28, 2024 -

November 24, 2024

446,461

69.02

446,461

46,945,305

Total

4,180,583

$

72.46

4,180,583

46,945,305

(a)

The total number

of shares purchased

includes shares of

common stock withheld

for the payment

of withholding taxes

upon the distribution

of

deferred option units.

(b)

On June

27, 2022,

our Board

of Directors approved

an authorization

for the

repurchase of

up to

100,000,000 shares of

our common stock

and

terminated the

prior authorization.

Purchases can

be made

in the

open market

or in

privately negotiated

transactions, including

the use

of call

options

and

other

derivative

instruments,

Rule

10b5-1

trading

plans,

and

accelerated

repurchase

programs.

The

Board

did

not

specify

an

expiration date for the authorization.